CRIS Current Research Information System

PICCI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.017
AS - Asia 5.506
EU - Europa 4.107
SA - Sud America 392
AF - Africa 318
Continente sconosciuto - Info sul continente non disponibili 280
OC - Oceania 14
Totale 17.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.894
VN - Vietnam 1.586
SG - Singapore 1.523
CN - Cina 1.214
GB - Regno Unito 956
IT - Italia 680
DE - Germania 583
SE - Svezia 523
HK - Hong Kong 449
BR - Brasile 275
FR - Francia 274
RU - Federazione Russa 269
IN - India 238
IE - Irlanda 169
UA - Ucraina 149
JP - Giappone 106
CH - Svizzera 105
ZA - Sudafrica 102
NL - Olanda 98
CI - Costa d'Avorio 90
BD - Bangladesh 73
KR - Corea 73
EE - Estonia 65
TG - Togo 58
CA - Canada 54
BG - Bulgaria 52
JO - Giordania 52
AR - Argentina 45
FI - Finlandia 45
BE - Belgio 35
PH - Filippine 30
ID - Indonesia 27
MX - Messico 26
TH - Thailandia 26
ES - Italia 22
PL - Polonia 22
SC - Seychelles 22
EC - Ecuador 20
IQ - Iraq 19
TR - Turchia 17
CO - Colombia 16
GR - Grecia 14
AT - Austria 13
AU - Australia 13
CR - Costa Rica 13
SA - Arabia Saudita 12
TW - Taiwan 12
CL - Cile 11
PK - Pakistan 9
UZ - Uzbekistan 9
VE - Venezuela 9
AL - Albania 7
JM - Giamaica 7
MA - Marocco 7
MY - Malesia 7
EG - Egitto 6
GT - Guatemala 6
PE - Perù 6
UY - Uruguay 6
ET - Etiopia 5
LB - Libano 5
LT - Lituania 5
NG - Nigeria 5
DZ - Algeria 4
HN - Honduras 4
IR - Iran 4
KE - Kenya 4
PY - Paraguay 4
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
GH - Ghana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BS - Bahamas 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HT - Haiti 1
IL - Israele 1
KH - Cambogia 1
Totale 17.344
Salva come PNG Salva come JPEG
Città #
Singapore 1.043
Southend 826
Ashburn 716
Fairfield 621
Chandler 520
San Jose 470
Hong Kong 432
Ho Chi Minh City 314
Woodbridge 310
Hanoi 305
Wilmington 293
Houston 284
Santa Clara 284
Seattle 267
Ann Arbor 263
Cambridge 239
Dong Ket 233
Princeton 229
Beijing 195
Dublin 170
Council Bluffs 148
Boardman 145
Hefei 126
Lauterbourg 111
Bern 92
Tokyo 92
Abidjan 90
Westminster 83
Nanjing 82
Jacksonville 79
Los Angeles 78
Padova 77
Bologna 76
Berlin 68
Turin 64
Seoul 59
Lomé 58
New York 53
Amman 52
Buffalo 52
Sofia 48
Bremen 46
Haiphong 44
Saint Petersburg 44
San Diego 44
Frankfurt am Main 41
Da Nang 38
Dallas 38
Hebei 38
Helsinki 38
Redondo Beach 37
Jinan 36
Milan 36
São Paulo 36
Falls Church 35
Shenyang 35
Brussels 34
Chicago 34
Guangzhou 32
Changsha 30
Nanchang 30
Des Moines 26
Phoenix 25
London 24
Tianjin 23
Mülheim 22
Zhengzhou 21
Florence 20
Redmond 20
Falkenstein 19
Medford 19
Rome 19
Dearborn 18
Düsseldorf 18
Brooklyn 17
Shanghai 17
Shenzhen 17
Amsterdam 16
Nuremberg 16
Olalla 16
San Francisco 16
Warsaw 16
Bengaluru 15
Hải Dương 15
Toronto 15
Jiaxing 14
Atlanta 13
Munich 13
Biên Hòa 12
Can Tho 12
Chengdu 12
Jakarta 12
Ningbo 12
Thái Nguyên 12
Bắc Giang 11
Johannesburg 11
Redwood City 11
The Dalles 11
Catanzaro 10
Haikou 10
Totale 11.119
Salva come PNG Salva come JPEG
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 331
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 257
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. 251
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 237
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 236
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 229
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. 226
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 226
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 225
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. 224
CD99 Acts as an Oncosuppressor in Osteosarcoma. 222
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 217
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 216
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 215
Clinical outcome of central conventional chondrosarcoma. 212
Spontaneous healing of an osteochondroma fracture. 207
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 207
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 206
Osteosarcoma follow-up: chest X-ray or computed tomography? 204
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 202
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 200
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 196
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. 195
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). 195
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 194
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 188
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases 186
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 182
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 182
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 181
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 180
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 178
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 176
Small cell osteosarcoma: Clinicopathologic, immunohistochemical, and molecular analysis of 36 cases 176
Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 174
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 171
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 171
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 170
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 169
NVE-BEZ235 as a new therapeutic option for sarcomas. 168
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 167
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 164
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 162
Molecular diagnosis in ewing family tumors the rizzoli experience-222 consecutive cases in four years 160
Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma? 159
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 159
Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group 158
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 158
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 158
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 157
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 155
Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. 154
The natural history of advanced inoperable central chondrosarcoma 154
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol 154
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 153
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 153
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 152
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis 151
Pediatric chondrosarcomas: a retrospective review of 17 cases 151
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 150
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 149
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 148
Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999 147
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 147
Genetic and Molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes. 145
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 145
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? 143
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 142
Sacral Chordoma: Long-term outcome of a large series of patients surgically treated at two reference centers 141
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 141
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature 141
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study 140
Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity 139
Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature 139
Advances in Bone Metastases Management 138
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 138
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results 138
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 137
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 136
Palliative therapy for osteosarcoma. 135
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 135
Epidemiology 134
Osteosarcoma teleangectasico: analisi clinico-patologica di 87 casi 133
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 133
Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. 131
Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma 131
Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients 130
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 130
Platelet-derived growth factors enhance proliferation of human stromal stem cells 126
Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, retrospective, multicenter study of the italian sarcoma group 124
Primary metastatic Ewing's family tumors:results of the Italian Sarcoma Group And Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. 121
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series 120
Reconstruction in the treatment of pelvic chondrosarcoma. 117
Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli 117
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction 117
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups 111
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors. 110
Imaging of bone tumours for the musculoskeletal oncology surgeon. 108
Palliative treatment: selective arterial embolisation for bone metastases. 107
Dedifferentiated chondrosarcoma: preliminary results from the European Bone over 40 sarcomas study, (EURO.B.O.S.S.) 104
Totale 16.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.700 0 0 125 136 185 123 46 139 67 176 391 312
2022/20232.258 227 283 123 300 142 144 74 142 387 69 183 184
2023/2024479 23 107 41 37 22 75 40 40 14 26 23 31
2024/20252.212 106 354 191 135 388 99 132 77 19 169 76 466
2025/20265.433 480 568 435 386 576 304 502 310 1.147 374 201 150
2026/2027670 143 180 347 0 0 0 0 0 0 0 0 0
Totale 17.634